JAZZ - Jazz Pharmaceuticals plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
8.49B
Enterprise Value 3
9.08B
Trailing P/E
14.22
Forward P/E 1
8.49
PEG Ratio (5 yr expected) 1
0.85
Price/Sales (ttm)
4.13
Price/Book (mrq)
2.75
Enterprise Value/Revenue 3
4.42
Enterprise Value/EBITDA 6
8.51

Trading Information

Stock Price History

Beta (3Y Monthly) 1.10
52-Week Change 33.25%
S&P500 52-Week Change 315.46%
52 Week High 3153.03
52 Week Low 3113.52
50-Day Moving Average 3133.30
200-Day Moving Average 3132.66

Share Statistics

Avg Vol (3 month) 3553.76k
Avg Vol (10 day) 3745.24k
Shares Outstanding 556.57M
Float 51.88M
% Held by Insiders 12.77%
% Held by Institutions 196.23%
Shares Short (Nov 15, 2019) 42.93M
Short Ratio (Nov 15, 2019) 45.78
Short % of Float (Nov 15, 2019) 45.31%
Short % of Shares Outstanding (Nov 15, 2019) 45.18%
Shares Short (prior month Oct 15, 2019) 42.9M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 29.61%
Operating Margin (ttm)40.09%

Management Effectiveness

Return on Assets (ttm)9.36%
Return on Equity (ttm)20.02%

Income Statement

Revenue (ttm)2.06B
Revenue Per Share (ttm)35.78
Quarterly Revenue Growth (yoy)14.60%
Gross Profit (ttm)1.77B
EBITDA 1.07B
Net Income Avi to Common (ttm)608.84M
Diluted EPS (ttm)10.44
Quarterly Earnings Growth (yoy)-31.50%

Balance Sheet

Total Cash (mrq)1.07B
Total Cash Per Share (mrq)18.92
Total Debt (mrq)1.77B
Total Debt/Equity (mrq)57.99
Current Ratio (mrq)3.89
Book Value Per Share (mrq)53.95

Cash Flow Statement

Operating Cash Flow (ttm)906.7M
Levered Free Cash Flow (ttm)674.13M